Evaluation of Factors II, VII, IX, X, and Proteins C and S, Following High-dose Vitamin K Supplementation
Completed · Not applicable
Conditions studied: Thrombosis
In brief
The purpose of this study is to evaluate factor levels of the pro coagulant factors II, VII, IX, X, and the anticoagulant factors protein C and S in healthy volunteers during the intake of elevated levels of vitamin K in order to investigate whether there is any evidence that high dose vitamin K intake increases plasma coagulation factor activity.
Key facts
- Study ID
- NCT01143831
- Run by
- Stephan Moll, MD
- People needed
- 8
- Starts
- 2009-11-01
- Expected to finish
- 2012-03-01
- Last updated by the study team
- 2012-06-12
Who can join
Age: 20 and older, up to 85. Sex: male. Healthy volunteers: accepted.
You may qualify if…
- Healthy adult male
You may not qualify if…
- prior history of arterial or venous thrombosis
Where it is running
- University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.